BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20463670)

  • 1. Xeroderma pigmentosum: a heterogeneous disease with pockets of homogeneity.
    Barron GS; Kirsner RS
    J Invest Dermatol; 2010 Jun; 130(6):1484. PubMed ID: 20463670
    [No Abstract]   [Full Text] [Related]  

  • 2. Founder mutations in xeroderma pigmentosum.
    Tamura D; DiGiovanna JJ; Kraemer KH
    J Invest Dermatol; 2010 Jun; 130(6):1491-3. PubMed ID: 20463673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
    Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
    J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ancient origin of a Japanese xeroderma pigmentosum founder mutation.
    Imoto K; Nadem C; Moriwaki S; Nishigori C; Oh KS; Khan SG; Goldstein AM; Kraemer KH
    J Dermatol Sci; 2013 Feb; 69(2):175-6. PubMed ID: 23194742
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel frameshift mutation in the XPC gene in a Moroccan patient: a case report.
    Doubaj Y; Smaili W; Laarabi FZ; Sefiani A
    J Med Case Rep; 2017 Jun; 11(1):158. PubMed ID: 28615033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
    Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
    Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of molecular defects in xeroderma pigmentosum group C.
    Li L; Bales ES; Peterson CA; Legerski RJ
    Nat Genet; 1993 Dec; 5(4):413-7. PubMed ID: 8298653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.
    Sarasin A; Quentin S; Droin N; Sahbatou M; Saada V; Auger N; Boursin Y; Dessen P; Raimbault A; Asnafi V; Schmutz JL; Taïeb A; Menck CFM; Rosselli F; La Rochelle LD; Robert C; Sicre de Fontbrune F; Sébert M; Leblanc T; Kannouche P; De Botton S; Solary E; Soulier J
    Blood; 2019 Jun; 133(25):2718-2724. PubMed ID: 30914417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xeroderma pigmentosum in South Africa: Evidence for a prevalent founder effect.
    Kgokolo M; Morice-Picard F; Rezvani HR; Austerlitz F; Cartault F; Sarasin A; Sathekge M; Taieb A; Ged C
    Br J Dermatol; 2019 Nov; 181(5):1070-1072. PubMed ID: 31017654
    [No Abstract]   [Full Text] [Related]  

  • 10. Carrier frequency of the recurrent mutation c.1643_1644delTG in the XPC gene and birth prevalence of the xeroderma pigmentosum in Morocco.
    Doubaj Y; Laarabi FZ; Elalaoui SC; Barkat A; Sefiani A
    J Dermatol; 2012 Apr; 39(4):382-4. PubMed ID: 22211393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four types of possible founder mutations are responsible for 87% of Japanese patients with Xeroderma pigmentosum variant type.
    Masaki T; Ono R; Tanioka M; Funasaka Y; Nagano T; Moriwaki S; Nishigori C
    J Dermatol Sci; 2008 Nov; 52(2):144-8. PubMed ID: 18703314
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetics and skin cancer of xeroderma pigmentosum in Japan.
    Takebe H; Nishigori C; Satoh Y
    Jpn J Cancer Res; 1987 Nov; 78(11):1135-43. PubMed ID: 3121549
    [No Abstract]   [Full Text] [Related]  

  • 13. [Translesion synthesis defective in the xeroderma pigmentosum variant cells].
    Masutani C; Hanaoka F
    Tanpakushitsu Kakusan Koso; 2001 Jun; 46(8 Suppl):1097-106. PubMed ID: 11436298
    [No Abstract]   [Full Text] [Related]  

  • 14. Tritiated thymidine: xeroderma pigmentosum and DNA repair.
    Cleaver JE
    FASEB J; 2014 Jul; 28(7):2742-5. PubMed ID: 24990958
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C.
    Legerski R; Peterson C
    Nature; 1992 Dec; 360(6404):610. PubMed ID: 1461286
    [No Abstract]   [Full Text] [Related]  

  • 16. Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation.
    Itoh T; Linn S; Kamide R; Tokushige H; Katori N; Hosaka Y; Yamaizumi M
    J Invest Dermatol; 2000 Dec; 115(6):981-5. PubMed ID: 11121129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum and nucleotide excision repair of DNA.
    Tanaka K; Wood RD
    Trends Biochem Sci; 1994 Feb; 19(2):83-6. PubMed ID: 8160271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum.
    Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
    Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
    Sugasawa K
    Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trichothiodystrophies: anomalies of the repair and transcription of genes].
    Robert C; Sarasin A
    Ann Dermatol Venereol; 1999 Oct; 126(10):669-71. PubMed ID: 10604001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.